Xu X - Search Results

1

lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.

Pan C, Chen G, Zhao X, Xu X, Liu J. Pan C, et al. Among authors: xu x. Eur J Pharmacol. 2022 Nov 5;934:175317. doi: 10.1016/j.ejphar.2022.175317. Epub 2022 Oct 7. Eur J Pharmacol. 2022. PMID: 36216119

2

FAK-targeting PROTAC demonstrates enhanced antitumor activity against KRAS mutant non-small cell lung cancer.

Liu J, Xue L, Xu X, Luo J, Zhang S. Liu J, et al. Among authors: xu x. Exp Cell Res. 2021 Nov 15;408(2):112868. doi: 10.1016/j.yexcr.2021.112868. Epub 2021 Oct 12. Exp Cell Res. 2021. PMID: 34648846

3

Circular RNA circFOXO3 facilitate non-small cell lung cancer progression through upregulating HMGB3 via sponging miR-545-3p/miR-506-3p.

Yang M, Zheng E, Ni J, Xu X, Jiang X, Zhao G. Yang M, et al. Among authors: xu x. Tissue Cell. 2022 Apr;75:101702. doi: 10.1016/j.tice.2021.101702. Epub 2021 Nov 25. Tissue Cell. 2022. PMID: 35038619

4

LncRNA RP11‑805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR‑34b‑3p and miR‑139‑5p in lung adenocarcinoma.

Zhu H, Xu X, Zheng E, Ni J, Jiang X, Yang M, Zhao G. Zhu H, et al. Among authors: xu x. Oncol Rep. 2022 Sep;48(3):161. doi: 10.3892/or.2022.8376. Epub 2022 Jul 22. Oncol Rep. 2022. PMID: 35866595 Free PMC article.

5

Endoplasmic Reticulum Stress-Related Four-Biomarker Risk Classifier for Survival Evaluation in Esophageal Cancer.

Xu X, Tang Y, Zhu J, Luo J. Xu X, et al. J Oncol. 2022 Mar 18;2022:5860671. doi: 10.1155/2022/5860671. eCollection 2022. J Oncol. 2022. PMID: 35342421 Free PMC article.

6

YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis.

Shen H, Zheng E, Yang Z, Yang M, Xu X, Zhou Y, Ni J, Li R, Zhao G. Shen H, et al. Among authors: xu x. Oncol Lett. 2020 Jul;20(1):43-52. doi: 10.3892/ol.2020.11560. Epub 2020 Apr 21. Oncol Lett. 2020. PMID: 32565932 Free PMC article.

7

Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition.

Xu X, Zhu H, Yang M, Zheng E, Zhou Y, Ni J, Li R, Yang Z, He T, Zhao G. Xu X, et al. Exp Ther Med. 2020 Mar;19(3):1925-1932. doi: 10.3892/etm.2019.8358. Epub 2019 Dec 20. Exp Ther Med. 2020. PMID: 32104250 Free PMC article.

8

Regionally surgical resection of stage-IV adenocarcinoma acquired tyrosine kinases inhibitor-resistance.

Yang M, Zheng E, Xu X, Ni J, Li J, Zhao G. Yang M, et al. Among authors: xu x. J Thorac Dis. 2019 Jan;11(1):255-258. doi: 10.21037/jtd.2018.12.105. J Thorac Dis. 2019. PMID: 30863599 Free PMC article. No abstract available.

9

A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report.

Ni J, Yang L, Zhu H, Chu M, Zhang C, Zhao W, Yang M, Xu X, Zheng E, Jiang X, Li R, Zhao G. Ni J, et al. Among authors: xu x. Ann Palliat Med. 2021 Apr;10(4):4999-5009. doi: 10.21037/apm-21-860. Ann Palliat Med. 2021. PMID: 33966436 Free article.

10

Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex.

Yang M, Tong X, Xu X, Zheng E, Ni J, Li J, Yan J, Shao YW, Zhao G. Yang M, et al. Among authors: xu x. Lung Cancer. 2018 Jul;121:1-4. doi: 10.1016/j.lungcan.2018.04.006. Epub 2018 Apr 5. Lung Cancer. 2018. PMID: 29858019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,484 results

Search Page

Filters